MedPath

'Effect of Diabetosit herbal supplement in treatment of Diabetes

Phase 3
Recruiting
Conditions
Type 2 diabetes mellitus.
Type 2 diabetes mellitus
Registration Number
IRCT20190728044350N1
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Over 30 years old
Under treatment with oral glucose-lowering drugs

Exclusion Criteria

Insulin dependent patients
History of heart disease or myocardial infarction
History of asthma and allergy to nettle
Hepatic insufficiency
Pregnancy or lactation
Thyroid diseases
Severe infection
Renal Insufficiency

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of patients with Fasting blood sugar lower than 140 mg/dl. Timepoint: At baseline and 8 weeks after study. Method of measurement: Biochemical tests are carried out by the Selectra autoanalyser. Total cholesterol will be measured enzymatically using cholesterol esterase and cholesterol oxidase. HDL-C is measured after deposition of lipoproteins containing APO-B by phosphotungstic acid with the same enzymatic method of total cholesterol. Triglycerides will be carried out enzymatically using glycerol phosphate oxidase. LDL-C is measured in serum samples with triglyceride levels equal or less than 400 mg / dl using the Freidwald formula.
Secondary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: At baseline and 8 weeks after. Method of measurement: Using mercury sphygmomanometer.
© Copyright 2025. All Rights Reserved by MedPath